Evidence map›Paper›PMID 41815953›Full record

ArticleThe World Allergy Organization journal2026

Global research trends in hereditary angioedema, 1972-2023: Bibliometric analysis of productivity, collaboration, and thematic evolution.

Hugo W F Mak, Hilary J Longhurst, Markus Magerl, Jonny Peter, Marc Riedl, Philip H Li

Abstract read
In one paragraph

Article in The World Allergy Organization journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hugo W F MakDivision of Rheumatology and Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong.
Hilary J LonghurstDepartment of Immunology, Auckland City Hospital, Grafton, Auckland, New Zealand.
Markus MagerlAngioedema Center of Reference and Excellence (ACARE), Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Jonny PeterDivision of Allergy and Clinical Immunology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Marc RiedlDivision of Rheumatology, Allergy, and Immunology, University of California, San Diego, La Jolla, CA, United States.
Philip H LiDivision of Rheumatology and Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hereditary angioedema (HAE) is a rare, potentially life-threatening condition. In recent years, the emergence of novel therapies has likely contributed to substantial growth in HAE research; however, a comprehensive review of the HAE research landscape remains lacking. Methods: We conducted a systematic literature search on the Web of Science Core Collection and extracted metadata for all HAE records from 1972 to 2023. Bibliometric analysis was performed to outline trends in research productivity, participation, collaboration, focus, and global patterns in HAE research. Results: We analysed a total of 2443 publications. Research output increased over time (annual growth rate = 6.34%) and was correlated to countries' Human Development Index and Gross National Income per capita (Spearman ρ > 0.40, p < 0.001). Regional analysis based on WHO classifications revealed >85% of HAE studies were led by researchers from Europe and America. However, contributions from the Western Pacific rose significantly (1972-2010: 4.6% vs 2011-2023: 8.6%, p < 0.001). International collaboration rose significantly over time, increasing from 10.9% (1972-2010) to 27.7% (2011-2023) (p < 0.001). Keyword and trend analyses indicated that research focus shifted from pathophysiology and diagnosis to patient outcomes, treatment and prophylaxis. Specifically, long-term prophylaxis emerged as a key area in recent research. Conclusions: The volume of HAE-related publications is rapidly increasing, reflecting a transition from basic science to more clinically oriented research, particularly focusing on long-term prophylaxis. While global research efforts are becoming increasingly collaborative and diverse, participation from Africa, the Eastern Mediterranean, and South-East Asia remains limited. Greater support for these regions is essential to ensure equitable progress in HAE research and care.

Indexed as

AngioedemaBibliometricC1–INHC1 inhibitorDeficiencyHereditaryProductivityResearchTrends

Identifiers

PMID41815953
PMCPMC12972517

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.